Conference Proceedings

Tolerability of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy in the randomized phase III tAnGo trial for invasive higher risk early stage breast cancer.

CJ Poole, L Hiller, HC Howard, S Loi, JA Dunn, P Canney, AM Wardley, JP Crown, RE Coleman, MW Verrill, PA Ellis, RC Leonard, D Spooner, HM Earl

BREAST CANCER RESEARCH AND TREATMENT | SPRINGER | Published : 2006